TL;DR: Aetna, a CVS Health company, modified CPB 0560 governing voice prosthesis coverage for voice rehabilitation following total laryngectomy, effective December 4, 2025. Billing teams should audit charge capture for HCPCS codes L8500 through L8515 and CPT 31611 before processing new claims under this updated policy.
This update to CPB 0560 in the Aetna system touches a narrow but financially meaningful patient population — total laryngectomy survivors seeking voice rehabilitation. The policy covers indwelling tracheo-esophageal (TE) prostheses, non-indwelling devices, hand-held artificial larynx devices, and related accessories. If your practice or DME supplier bills L8507, L8509, or L8511 for Aetna members, this policy sets the rules for reimbursement.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Voice Prosthesis for Voice Rehabilitation Following Total Laryngectomy |
| Policy Code | CPB 0560 |
| Change Type | Modified |
| Effective Date | December 4, 2025 |
| Impact Level | Medium — narrow patient population but high per-claim value |
| Specialties Affected | Otolaryngology, Head & Neck Surgery, Speech-Language Pathology, DME Suppliers |
| Key Action | Verify that claims for TE prosthesis replacement include SLP or laryngologist recommendation and correct HCPCS codes before submitting |
Aetna Voice Prosthesis Coverage Criteria and Medical Necessity Requirements 2025
The Aetna voice prosthesis coverage policy under CPB 0560 has a clear structure. If you know it, claim denials on this patient population should be rare.
Indwelling TE Voice Prostheses
Aetna covers indwelling TE voice prostheses when a laryngologist or speech-language pathologist (SLP) recommends them for voice rehabilitation after total laryngectomy. Medical necessity requires that recommendation — a physician order alone won't cut it without the specialist recommendation documented.
Replacement of the indwelling prosthesis is also covered. Aetna recognizes a three to six month lifespan as consistent with clinical evidence for most devices. Replacement is typically an outpatient procedure billed under L8509 (provider-inserted) or L8507 (patient-inserted, non-indwelling devices). If you're billing L8511 for inserts, that's covered as a replacement accessory.
Named indwelling devices under this coverage policy include the Blom-Singer Indwelling Low-Pressure Voice Prosthesis, the Provox 2, and the VoiceMaster. Knowing the device your facility uses matters for documentation — payers increasingly tie medical necessity reviews to specific device categories.
Hand-Held Artificial Larynx Devices
Aetna considers hand-held artificial larynx devices medically necessary without additional selection criteria layered on top. Covered devices include the Nu Vois, OptiVox, Servox, SolaTone, TruTone, and UltraVoice. These bill under HCPCS L8500. Batteries and accessories for these devices fall under L8505.
This is a relatively clean coverage path. The medical necessity standard here doesn't require a specialist recommendation — it's a broader coverage grant than the TE prosthesis category.
Non-Indwelling Voice Prostheses
Non-indwelling voice prostheses, such as the Provox NiD, carry the same specialist recommendation requirement as indwelling devices. A laryngologist or SLP must recommend the device for voice rehabilitation following total laryngectomy. Bill these under L8507.
The same selection criteria referenced in the policy appendix govern both indwelling and non-indwelling TE prostheses. Make sure your documentation package reflects those criteria — not just a generic SLP note, but one that addresses the selection rationale.
Prior Authorization
The policy itself does not list a blanket prior authorization requirement for all voice prosthesis billing. That said, Aetna plan designs vary. Check eligibility and benefits before submitting claims for prosthesis insertion (CPT 31611) or device supply codes. Some commercial plans layer prior auth requirements on top of the clinical policy. Call the number on the member's card or run an eligibility check before assuming open access.
Aetna Voice Prosthesis Exclusions and Non-Covered Indications
Two categories are explicitly off the table under CPB 0560.
Aetna considers Pneumatic Bionic Voice Prostheses experimental, investigational, and unproven. Clinical value hasn't been established to Aetna's standard. Claims for these devices will deny. Don't submit them without escalating to your compliance officer first — if a patient's physician is recommending one, you may be in exception territory, and that requires a different process.
Aetna also considers use of a TE voice prosthesis insufflator experimental, investigational, and unproven. Same standard — clinical value not established. This is worth flagging to your DME team specifically, since insufflators can appear as add-on accessories in prosthesis kits. Bill those kits carefully.
If your facility is exploring newer pneumatic or bionic voice prosthesis technologies, document that you understand Aetna won't cover them. Patients need to know before treatment, not after a claim denial.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Indwelling TE voice prosthesis after total laryngectomy | Covered | L8509, CPT 31611 | Laryngologist or SLP recommendation required; selection criteria must be met |
| Replacement of indwelling TE voice prosthesis | Covered | L8509, L8511 | Every 3–6 months consistent with clinical evidence; outpatient procedure |
| Hand-held artificial larynx device | Covered | L8500 | No specialist recommendation requirement; devices include Nu Vois, Servox, TruTone, others |
| Artificial larynx battery/accessory | Covered | L8505 | Covered as accessory to L8500 devices |
| Non-indwelling TE voice prosthesis (e.g., Provox NiD) | Covered | L8507 | Laryngologist or SLP recommendation required; selection criteria must be met |
| Tracheostomy speaking valve | Covered | L8501 | Covered if selection criteria are met |
| TE prosthesis inserts, cleaning devices, dilators, gelatin capsules | Covered | L8511, L8512, L8513, L8514, L8515 | Replacement items only; covered as accessories to prosthesis |
| Pneumatic Bionic Voice Prostheses | Experimental / Not Covered | — | Clinical value not established; claims will deny |
| TE voice prosthesis insufflator | Experimental / Not Covered | — | Clinical value not established; do not bill as standard accessory |
Aetna Voice Prosthesis Billing Guidelines and Action Items 2025
Here's what your billing team needs to do before submitting claims under the updated CPB 0560.
1. Verify specialist recommendation documentation before December 4, 2025 claims go out.
For every TE prosthesis claim — indwelling (L8509) or non-indwelling (L8507) — your file needs a documented recommendation from a laryngologist or SLP. A physician order from a generalist isn't enough. Pull a sample of recent claims and confirm documentation matches.
2. Audit your HCPCS codes against device type.
L8507 covers patient-inserted TE prostheses. L8509 covers provider-inserted. These are not interchangeable. Miscoding between L8507 and L8509 is a common error and a straight path to a claim denial. Confirm your charge capture routes each device to the correct code.
3. Flag any Pneumatic Bionic Voice Prosthesis orders immediately.
If a physician orders a pneumatic bionic device, do not bill it to Aetna expecting payment. It's experimental under this coverage policy. Talk to your compliance officer and the ordering physician before any service is rendered. The patient may need an Advance Beneficiary Notice or plan exception process.
4. Don't bundle insufflators into prosthesis supply claims.
The TE voice prosthesis insufflator is experimental. If your supply kits include insufflators, strip them out of Aetna claims. Bundling an excluded item with covered accessories creates a claim integrity problem — not just a denial risk.
5. Build a replacement schedule for indwelling prostheses.
The three to six month replacement cadence is clinically supported and covered. Build that into your scheduling and charge capture workflow. Regular replacement claims should include the ICD-10 code Z90.02 (acquired absence of larynx) to establish ongoing medical necessity in the record.
6. Confirm prior authorization requirements at the plan level.
CPB 0560 billing guidelines don't mandate prior auth across all plans, but commercial plan designs can add that requirement. Run eligibility before billing CPT 31611 (tracheoesophageal fistula construction and prosthesis insertion). A denied 31611 claim for missing prior auth is expensive and avoidable.
7. Check ICD-10 coding on all claims.
Primary claims for laryngectomy survivors typically carry C32.x (malignant neoplasm of larynx), Z85.21 (personal history of malignant neoplasm of larynx), or Z90.02 (acquired absence of larynx). Don't mismatch an active malignancy code with a post-laryngectomy prosthesis claim unless the patient is still in active treatment. Payers review diagnosis code logic.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Voice Prosthesis Under CPB 0560
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 31611 | CPT | Construction of tracheoesophageal fistula and subsequent insertion of an alaryngeal speech prosthesis |
Covered HCPCS Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| L8500 | HCPCS | Artificial larynx, any type |
| L8501 | HCPCS | Tracheostomy speaking valve |
| L8505 | HCPCS | Artificial larynx replacement battery/accessory, any type |
| L8507 | HCPCS | Tracheo-esophageal voice prosthesis, patient inserted, any type, each (e.g., the Provox NiD) |
| L8509 | HCPCS | Tracheo-esophageal voice prosthesis, inserted by a licensed health care provider, any type |
| L8511 | HCPCS | Insert for indwelling tracheoesophageal prosthesis, with or without valve, replacement only, each |
| L8512 | HCPCS | Gelatin capsules or equivalent, for use with tracheoesophageal voice prosthesis, replacement only |
| L8513 | HCPCS | Cleaning device used with tracheoesophageal voice prosthesis, pipet, brush, or equal, replacement only |
| L8514 | HCPCS | Tracheoesophageal puncture dilator, replacement only, each |
| L8515 | HCPCS | Gelatin capsule, application device for use with tracheoesophageal voice prosthesis, each |
Key ICD-10-CM Diagnosis Codes
| Code | Description |
|---|---|
| C32.0 | Malignant neoplasm of larynx |
| C32.1 | Malignant neoplasm of larynx |
| C32.2 | Malignant neoplasm of larynx |
| C32.3 | Malignant neoplasm of larynx |
| C32.4 | Malignant neoplasm of larynx |
| C32.5 | Malignant neoplasm of larynx |
| C32.6 | Malignant neoplasm of larynx |
| C32.7 | Malignant neoplasm of larynx |
| C32.8 | Malignant neoplasm of larynx |
| C32.9 | Malignant neoplasm of larynx |
| D02.0 | Carcinoma in situ of larynx |
| D14.1 | Benign neoplasm of larynx |
| Z85.21 | Personal history of malignant neoplasm of larynx |
| Z90.02 | Acquired absence of larynx |
Z90.02 is your workhorse code for ongoing prosthesis replacement claims. C32.x codes are appropriate for patients still in active treatment or with residual/recurrent disease. Z85.21 applies to patients with a prior history of laryngeal cancer who have completed treatment. Match the diagnosis code to the patient's current clinical status — not just the admission diagnosis.
Get the Full Picture for CPT 31611
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.